Search Results
Bezlotoxumab for Prevention of Clostridium difficile Infection Recurrence
Bezlotoxumab for Prevention of Recurrent C. Difficile Infection
Bezlotoxumab for prevention of recurrent C. Difficile infection
Zinplava (bezlotoxumab)- recurrence of Clostridium difficile infection (CDI)
Clinical Implications of Bezlotoxumab for Recurring C Diff Infections
Bezlotoxumab More Effective in Patients with High Risk for C Diff Recurrence
Clostridium Difficile: The Role of Bezlotoxumab
Clostridium Difficile: The Role of Bezlotoxumab
Factors That Impact Clostridium Difficile Infection Recurrence
Treatment and Prevention of Clostridium difficile Infection
Treatment and/or Prevention or Recurrence of CDI
C difficile: A Change in First-Line Treatment and New Biologic Agent
